Cargando…

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study

BACKGROUND: Omalizumab may modulate airway remodeling in severe asthma. Using forced expiratory volume in 1 second (FEV(1)) as a surrogate of airway remodeling, we aimed to investigate if an omalizumab add-on in severe allergic asthma may lead to a persistent reversal of airway obstruction and to ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solidoro, Paolo, Patrucco, Filippo, de Blasio, Francesca, Brussino, Luisa, Bellocchia, Michela, Dassetto, Davide, Pivetta, Emanuele, Riccio, Annamaria, Heffler, Enrico, Canonica, Walter, Rolla, Giovanni, Bucca, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475845/ https://www.ncbi.nlm.nih.gov/pubmed/31002021 http://dx.doi.org/10.1177/1753466619841274

Ejemplares similares

Asthmatic Patients with Vitamin D Deficiency have Decreased Exacerbations after Vitamin Replacement
por: Solidoro, Paolo, et al.
Publicado: (2017)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022)

Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?
por: Solidoro, Paolo, et al.
Publicado: (2022)

Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients
por: Malinovschi, Andrei, et al.
Publicado: (2014)

Eosinophils Target Therapy for Severe Asthma: Critical Points
por: Brussino, L., et al.
Publicado: (2018)

Laryngeal Spasm Mimicking Asthma and Vitamin D Deficiency
por: Masoero, Monica, et al.
Publicado: (2014)

Is it severe asthma or asthma with severe comorbidities?
por: Brussino, Luisa, et al.
Publicado: (2017)

325 Exercise-induced Airway Obstruction and Vitamin D Deficiency
por: Varenni, Davide, et al.
Publicado: (2012)

Retraction: Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease
por: Aredano, Ilaria, et al.
Publicado: (2020)

Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease
por: Aredano, Ilaria, et al.
Publicado: (2020)

Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
por: Mauri, Pierluigi, et al.
Publicado: (2014)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
por: Bagnasco, Diego, et al.
Publicado: (2018)

Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps
por: Boita, Monica, et al.
Publicado: (2016)

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
por: Canonica, Giorgio Walter, et al.
Publicado: (2018)

Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer
por: Nicola, Stefania, et al.
Publicado: (2021)

Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease
por: Bellocchia, Michela, et al.
Publicado: (2013)

Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months
por: Riccio, Anna Maria, et al.
Publicado: (2017)

Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients
por: Brunetta, Enrico, et al.
Publicado: (2018)

Lung function in relation to six-minute walk test in pulmonary hypertension
por: Farkhooy, Amir, et al.
Publicado: (2020)

Critical evaluation of asthma biomarkers in clinical practice
por: Guida, Giuseppe, et al.
Publicado: (2022)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

“Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study”
por: Losappio, Laura, et al.
Publicado: (2019)

Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
por: Scichilone, Nicola, et al.
Publicado: (2015)

Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
por: Heffler, Enrico, et al.
Publicado: (2015)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement
por: Nicola, Stefania, et al.
Publicado: (2020)

31 Nasal Nitric Oxide and Nasal Polyposis as Determinants of Asthma Control
por: Heffler, Enrico, et al.
Publicado: (2012)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Plasma Galectin-3 and urine proteomics predict FEV(1) improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study()
por: Riccio, Anna Maria, et al.
Publicado: (2020)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)

COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
por: Nicola, Stefania, et al.
Publicado: (2022)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

Th1- and Th17-Related Cytokines in Venous and Arterial Blood of Sclerodermic Patients with and without Digital Ulcers
por: Nicola, S., et al.
Publicado: (2019)

Itraconazole as “bridge therapy” to anti-IgE in patients with severe asthma with fungal sensitization
por: Pizzimenti, Stefano, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g5g2m2kg51i03sbocrth2utirf